6-methyl-1,3,8-trichlorodibenzofuran has been researched along with tamoxifen in 1 studies
Studies (6-methyl-1,3,8-trichlorodibenzofuran) | Trials (6-methyl-1,3,8-trichlorodibenzofuran) | Recent Studies (post-2010) (6-methyl-1,3,8-trichlorodibenzofuran) | Studies (tamoxifen) | Trials (tamoxifen) | Recent Studies (post-2010) (tamoxifen) |
---|---|---|---|---|---|
25 | 0 | 3 | 20,630 | 2,227 | 6,256 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Calvin, J; McDougal, A; Safe, S; Wormke, M | 1 |
1 other study(ies) available for 6-methyl-1,3,8-trichlorodibenzofuran and tamoxifen
Article | Year |
---|---|
Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective aryl hydrocarbon receptor modulator.
Topics: Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Benzofurans; Bone Development; Cysteine Endopeptidases; Drug Synergism; Estrogen Receptor Modulators; Female; Mammary Neoplasms, Experimental; Multienzyme Complexes; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Receptors, Aryl Hydrocarbon; Tamoxifen; Uterus | 2001 |